Oral etoposide and palliative treatment for small-cell lung cancer

This publication has 5 references indexed in Scilit:

• Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis
  British Journal of Cancer, 1996
• 84 Phase II study of topotecan in refractory and sensitive small cell lung cancer (SCLC)
  European Journal Of Cancer, 1995
• Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
  Journal of Clinical Oncology, 1995
• The role of radiation oncology in small cell lung cancer
  Critical Reviews in Oncology/Hematology, 1994
• Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer
  New England Journal of Medicine, 1993